Company news

Share this article:
Mylan Pharmaceuticals has entered into a deal with Novartis to market letrozole 2.5 mg tablets, a generic version of Novartis's breast cancer product Femara. Letrozole tablets posted U.S. sales of approximately $470 million for the 12 month period ending Sept. 30, 2008, according to a Mylan statement. 
 
Titan Pharmaceuticals, a manufacturer focused primarily on the development and commercialization of Probuphine, a treatment for opiate addiction, has reduced its workforce by 40%. Further staff reductions are anticipated in the next several weeks, a company statement said. 
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.